Euclides Nenga Manuel Sacomboio

Euclides Nenga Manuel Sacomboio


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
TLTeresa António António Luzembo
Teresa António António Luzembo
Fausto AlmeidaFausto Almeida
Fausto Almeida
According to the Angolan Ministry of Health, in 2023, 10.3 million cases of malaria were reported, an increase of 23% compared to 2022, however, with several deaths 10,089, against 12,480 in 2022, representing a percentage reduction of 19%. Background/Objectives: To investigate whether blood groups (ABO/Rh) can influence the response of biochemical markers in Plasmodium falciparum infection in patients admitted to some hospital units in Luanda/Angola. Methods: A longitudinal, prospective, and analytical study was carried out on 518 patients hospitalized for malaria in two hospital units in Luanda. Results: Of the 518 malaria patients included in the study, the ORh+ group represented (44.6%), followed by ARh+ (22.2%), BRh+ (22.0%), ABRh+ (6.9%), ORh- (2.7%), ARh- (1.0%) and BRh- (0.6%). Regarding sociodemographic data, there was no statistically significant relationship between age groups, area of residence, serum concentration of creatinine, urea, glucose, ALT, gamma GT, degree of parasitemia, antimalarial treatment, clinical condition, and clinical outcomes with blood groups (P < 0.05). However, there was a statistical relationship between gender, employment status, the blood concentration of direct bilirubin, total bilirubin, and AST with blood groups (P < 0.05). Conclusions: It was evident that the biochemical markers in the response to malaria infection can be influenced by the blood type of the individuals, especially direct bilirubin, total bilirubin, and AST, which showed a statistical relationship with the blood type of the patients studied.

4 December 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
TPTelma Patrícia Pereira Paulo
Telma Patrícia Pereira Paulo
ECEdson Cassinela
Edson Cassinela
CSCruz Sebastião
Cruz Sebastião
Background: Resistance to antimalarial drugs often used in emerging countries, including combination therapies, has forced scientists to search for and develop drugs with novel mechanisms of action, especially resistance to Plasmodium falciparum and Plasmodium vivax, which are highly prevalent in Southeast Asia, Africa, and South America. Objective: evaluate whether there is a relationship between urinalysis and resistance to in-hospital treatment of malaria in Angola. Methodology: This was a cross-sectional, prospective study with a quantitative approach. Results: of the 214 patients, the resistance rate was 24.1%, men (53.6%), between 21 and 40 years old (72.7%), employees (46.4%), from peri-urban regions (77.7%), treated with artemether (90.9), with high parasitemia (57.7%) and after 5 days of treatment, remained hospitalized (61.4%). Was a significant relationship between resistance in unemployed individuals [OR: 0.03 (95% CI: 0.01-0.29), p =0.003] and high levels of parasitemia [OR: 1.09 (95% CI: 1.09-3.95), p=0.040], remained hospitalized for more than 5 days [OR: 5.28 (95% CI: 0.65-43.1), p=0.121] and death [OR: 2.59 (95% CI: 0.32-20.9), p=0.371] when compared with other subgroups. Was a significant relationship between resistance to clear urine [OR: 5.55 (95% CI: 0.72-42.7), p =0.016], few urinary crystals [OR: 11.3 (95% CI: 5.07-25.3), p <0.001] and who presented some microorganisms that were not bacteria or fungi [OR: 3.02 (95% CI: 1 .32-6.90), p=0.009]. Conclusion: urine results, especially the appearance of cloudy urine, the presence of few crystals, and the presence of other microorganisms that are not bacteria or fungi, may be clear signs of resistance to hospital treatment with injectable antimalarials.

11 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
ESEuclides Nenga Manuel Sacomboio
Euclides Nenga Manuel Sacomboio
SZSanto Doqui Zua
Santo Doqui Zua
ATAdelino Tchivango
Adelino Tchivango
APAntónio Pululu
António Pululu
ACAdilson Caumba
Adilson Caumba
JMJoana Morais
Joana Morais
Introduction: Malaria continues to be the main cause of hospitalization and death in Angola, a sub-Saharan African country. In 2023, in the first quarter, 2,744,682 cases were registered, and of these 2,673 patients died due to the malaria disease. Previous studies showed that the ABO blood group can affect the progression of malaria to serious situations after P. falciparum infection while the sickle cell gene offers relative protection. Objective: We investigated changes in the blood count according to blood groups (ABO/Rh) and sickle cell trait in patients with malaria in Luanda, the capital city of Angola. Methodology: This was a longitudinal, prospective, and observational study with 198 patients hospitalized for malaria. Results: of the 198 patients studied, 13(6.6%) were ABRh(+), 4(2.0%) were ARh(-), 49(24.7%) were ARh(+), 42(21,2%) were BRh(+), 5(2.5%) were ORh(-), and 85(42.9%) were ORh(+). For sickle cell trait, 145(73.2%) were AA, 37(18.7%) were AS and 16(8.1%) were SS. No statistical relationship was observed between age group, sex, parasitemia, clinical picture, hematocrit, MCV, MCH, MCHC, WCB, NEUT, LINF, and PTL values with blood groups (p0.05). There was no relationship between age, parasitemia, clinical condition, MCV, MCH and MCHC, WCB, NEUT, and LINF values with sickle cell trait (p0.05). Conclusion: It is very important to differentiate patients with malaria based on blood groups and sickle cell trait, taking into account mainly the blood count parameters that demonstrate that there are patients who, depending on their blood group or sickle cell trait, may react weakly to the infection by malaria regardless of the degree of parasitemia and medical prognosis.